JP Morgan Chase’s BioNTech BNTX Stock Holding History

JP Morgan Chase’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.89M	Sell	20,000 -22,500	-53%	-$2.12M	﹤0.01%	4237
2026 Q1	$3.62M	Buy	42,500 +27,500	+183%	+$2.83M	﹤0.01%	3619
2025 Q4	$1.43M	Hold	15,000	–	–	﹤0.01%	4361
2025 Q3	$1.48M	Hold	15,000	–	–	﹤0.01%	4304
2025 Q2	$1.6M	Hold	15,000	–	–	﹤0.01%	4082
2025 Q1	$1.37M	Hold	15,000	–	–	﹤0.01%	4134
2024 Q4	$1.71M	Hold	15,000	–	–	﹤0.01%	4266
2024 Q3	$1.78M	Buy	15,000 +3,400	+29%	+$313K	﹤0.01%	4088
2024 Q2	$932K	Buy	+11,600	New	+$1.06M	﹤0.01%	4323
2023 Q1	–	Sell	-4,000	Closed	-$601K	–	6703
2022 Q4	$601K	Buy	+4,000	New	+$616K	﹤0.01%	4397
2022 Q1	–	Sell	-14,400	Closed	-$3.71M	–	6603
2021 Q4	$3.71M	Buy	14,400 +8,000	+125%	+$2.19M	﹤0.01%	3308
2021 Q3	$1.75M	Sell	6,400 -11,000	-63%	-$3.5M	﹤0.01%	3890
2021 Q2	$3.9M	Sell	17,400 -32,500	-65%	-$6.13M	﹤0.01%	3272
2021 Q1	$5.45M	Sell	49,900 -28,300	-36%	-$3.01M	﹤0.01%	2890
2020 Q4	$6.38M	Sell	78,200 -194,300	-71%	-$19.1M	﹤0.01%	2601
2020 Q3	$18.2M	Buy	+272,500	New	+$19.6M	﹤0.01%	1553

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

JP Morgan Chase's BNTX Position: Q2 2026 in Review

JP Morgan Chase increased its BioNTech (BNTX) stake by 8.3% in Q2 2026, buying an estimated $914K and bringing the position to 126,975 shares worth $12M. The position accounts for ﹤0.01% of the portfolio, ranked #2649.

JP Morgan Chase first reported a position in BNTX in Q1 2020 and has held it in 26 quarters since. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

JP Morgan Chase held 126,975 shares of BioNTech worth $12M as of Q2 2026.
JP Morgan Chase bought 9,707 BioNTech shares in Q2 2026, an estimated $914K.
BioNTech made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #2649 holding.
JP Morgan Chase first reported a position in BioNTech in Q1 2020 and has held it in 26 quarters since.
282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.